Facilitating bias in cost-effectiveness analysis: CHEERS 2022 and the creation of assumption-driven imaginary value claims in health technology assessment [version 1; peer review: 3 approved]

The current standards for health technology cost-effectiveness assessment rest on the creation of lifetime assumption-driven modeled simulations for imaginary pricing and consequent patient access recommendations. A recent BMJ paper reports a detailed assessment of 8,192 cost-effectiveness analyses,...

Full description

Bibliographic Details
Main Author: Paul Langley
Format: Article
Language:English
Published: F1000 Research Ltd 2022-09-01
Series:F1000Research
Subjects:
Online Access:https://f1000research.com/articles/11-993/v1